Trusted by:

clients clients clients clients clients clients clients clients clients clients
Newswise: Applied Materials and National University of Singapore Expand Semiconductor Research Lab
Release date: 24-Oct-2024 7:20 AM EDT
Applied Materials and National University of Singapore Expand Semiconductor Research Lab
National University of Singapore (NUS)

Applied Materials South East Asia Pte. Ltd. and the National University of Singapore (NUS) are furthering their collaboration to bring advanced semiconductor research capabilities and talent development opportunities to Singapore. The Applied Materials-NUS Advanced Materials Corporate Lab – established in 2018 and located on the NUS Kent Ridge campus – will be expanded with state-of-the-art semiconductor process equipment in a larger, more advanced cleanroom. In addition, Applied Materials and NUS are collaborating on programmes designed to strengthen Singapore’s talent pipeline.

Newswise: Exploring Reasons for Higher Breast Cancer Risk Among Caribbean Women
Released: 24-Oct-2024 7:00 AM EDT
Exploring Reasons for Higher Breast Cancer Risk Among Caribbean Women
Sylvester Comprehensive Cancer Center

Breast cancer takes a major toll on Caribbean women. They are often diagnosed at a younger age than women in the U.S., and have one of the highest mortality rates worldwide. A new study in JAMA Network Open suggests that these higher rates may be linked to shifting patterns in reproductive health.

Not for public release

This news release is embargoed until 24-Oct-2024 7:00 AM EDT Released to reporters: 21-Oct-2024 9:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 24-Oct-2024 7:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

22-Oct-2024 11:25 AM EDT
New AI Tool Predicts Protein-Protein Interaction Mutations in Hundreds of Diseases
Cleveland Clinic

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication.

Newswise: Blooming Revelations: The Complete Carnation Genome Assembled
Released: 23-Oct-2024 9:35 PM EDT
Blooming Revelations: The Complete Carnation Genome Assembled
Chinese Academy of Sciences

Carnations, prized for their diverse colors and long vase life, have had their genomes completely sequenced, marking a significant advancement in floral biology. This study offers detailed insights into the genetic underpinnings of this popular flower, crucial for guiding breeding programs aimed at enhancing its aesthetic and practical qualities. The comprehensive genome map provides a foundation for exploring the complex interplay between gene expression and the carnation's rich phenotypic variation.

Newswise: Boosting Kiwifruit's Immunity: Transcription Factors Prove Crucial in Disease Resistance
Released: 23-Oct-2024 9:10 PM EDT
Boosting Kiwifruit's Immunity: Transcription Factors Prove Crucial in Disease Resistance
Chinese Academy of Sciences

Researchers have made a key discovery in agricultural science, identifying transcription factors AcREM14 and AcC3H1 that significantly boost kiwifruit’s resistance to Pseudomonas syringae pv. actinidiae, the bacterium behind the devastating bacterial canker.

Released: 23-Oct-2024 5:05 PM EDT
Critical Steps and More Research Needed to Support Physicians’ Mental Health, Experts Say
Michigan Medicine - University of Michigan

A review of what's known about the crisis in physician well-being, and what can be done to address it, also suggests a need for action by health systems, and more research.

Released: 23-Oct-2024 4:50 PM EDT
Pesquisadores da Mayo Clinic utilizam terapia com feixe de prótons para tratar distúrbio do ritmo cardíaco
Mayo Clinic

A radioterapia é um tratamento comum para o câncer, mas ela poderia também ajudar a tratar ritmos cardíacos nocivos? A Mayo Clinic concluiu recentemente o primeiro ensaio clínico em humanos utilizando a terapia com feixe de prótons, um tipo de radiação para tratar pacientes com arritmias potencialmente fatais. Os pesquisadores afirmam que os resultados iniciais são encorajadores.

Released: 23-Oct-2024 4:25 PM EDT
Investigadores de Mayo Clinic utilizan la terapia con haz de protones para tratar trastorno del ritmo cardíaco
Mayo Clinic

La radioterapia es un tratamiento común para el cáncer, ¿pero también podría ayudar a tratar los ritmos cardíacos perjudiciales? Mayo Clinic recientemente concluyó el primer ensayo clínico en humanos utilizando la terapia con haz de protones, un tipo de radiación para tratar a pacientes con arritmias potencialmente mortales. Los investigadores afirman que los resultados iniciales son alentadores.

Released: 23-Oct-2024 4:25 PM EDT
Mayo Clinic Researchers Use Proton Beam Therapy to Treat Heart Rhythm Disorder
Mayo Clinic

Radiation therapy is a common treatment for cancer, but could it also help treat dangerous heart rhythms? Mayo Clinic recently completed the first clinical trial in humans using proton beam therapy, a type of radiation, to treat patients with potentially life-threatening arrhythmias. They say initial results are encouraging.


close
1.64319